FUT4 and breast cancer: A study by Yang et al. (131) confirms that inhibiting the expression of the Fut4 in breast cancer cells leads to a reduced expression of EMT markers, such as N-cadherin and vimentin, as well as an inhibition of the PI3K/Akt pathway.